STOCK TITAN

Karyopharm: Affinity reports 6.5% warrant stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Karyopharm Therapeutics Inc. (KPTI) reports that Affinity Asset Advisors, LLC and its managing member, Michael Cho, beneficially owned 1,573,517 shares issuable upon exercise of warrants as of September 30, 2026. The shares are directly held by Affinity Healthcare Fund, LP; the Adviser exercises voting and investment power over them, and Cho may be deemed a beneficial owner through his role as the Adviser’s managing member. The reported stake was 6.5%, calculated using a 24,254,977-share denominator as of August 6, 2026: 22,681,460 common shares outstanding plus 1,573,517 shares issuable upon warrant exercise. The warrants are subject to a 9.99% beneficial ownership limitation.

Beneficially owned warrant shares 1,573,517 shares Shares issuable upon exercise of warrants, as of September 30, 2026
Reported ownership percentage 6.5% As of September 30, 2026
Ownership-percentage denominator 24,254,977 shares As of August 6, 2026; consists of 22,681,460 common shares outstanding plus 1,573,517 shares issuable upon warrant exercise
Common shares outstanding 22,681,460 shares As of August 6, 2026
Beneficial ownership limitation 9.99% Limit applicable to the warrants after giving effect to issuance of warrant shares
Beneficial Ownership Limitation regulatory
"subject to a beneficial ownership limitation of 9.99%"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Warrants financial
"shares issuable upon the exercise of warrants"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
investment management agreement financial
"pursuant to an investment management agreement"
An investment management agreement is a written contract that hires a professional to make buying, selling and strategy decisions for an investment account or fund, and sets out their duties, fees, risk limits, performance measures and reporting requirements. It matters to investors because the agreement determines who controls the money, how much the service costs, what risks are allowed, and how success or failure is measured—think of it as the service contract that defines expectations and remedies for a hired portfolio manager.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KPTI shares did Affinity report beneficial ownership of?

Affinity Asset Advisors, LLC and Michael Cho reported beneficial ownership of 1,573,517 shares issuable upon exercise of warrants as of September 30, 2026. The shares are directly held by Affinity Healthcare Fund, LP.

What is the beneficial ownership limit on the KPTI warrants?

The warrants are subject to a 9.99% beneficial ownership limitation, measured against Karyopharm common shares outstanding immediately after giving effect to the warrant-share issuance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





48576U205

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Affinity Asset Advisors, LLC
Signature:/s/ Andrew Weinstein
Name/Title:Andrew Weinstein, Chief Financial Officer and Chief Compliance Officer
Date:11/13/2026
Michael Cho
Signature:/s/ Michael Cho
Name/Title:Michael Cho, Self
Date:11/13/2026

Keep reading